CGT Global Blog
CGT Global News
Stay ahead in the dynamic world of Accelerating Cell and Gene Therapy with the CGT Global blog and news page. Explore insightful articles, industry updates, product updates, and expert analysis on all things CGT Global. Stay informed, inspired, and connected with CGT Global – your go-to source for cutting-edge insights in the ever-evolving realm of research, clinical projects and healthcare.
Finding a Target in Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDA) is an aggressive and difficult malignancy to treat and accounts for one of the highest cancer death rates in the US. PDA encompasses 85% of all pancreatic cancers and has a 5% survival rate five years after diagnosis. Given the severity of the disease, it is imperative to find a cure or even a treatment that increases the survival rate of afflicted individuals. PDA comprises a dense fibrous stroma that has a heterogeneous population of cells, including fibroblasts,…
Read MoreGeneration of Large Intestinal Organoid
The workings of the human body have long been studied, ranging from the development of an organism to the diseases that inevitably bring about their demise. Much of the research into the mechanisms of development and disease utilizes cell lines or animals such as mice. Although scientific advances have been made using these model systems, they tend to be physiologically irrelevant in creating effective therapies for humans. As a result of three-dimensional (3D) cell culture methods, many aspects of stem cell differentiation…
Read MoreImprovements in NIPS Results from Maternal Blood
Chromosome aneuploidies are common genetic defects that can lead to diseases such as Down syndrome. Current methods of aneuploidy testing exist, primarily in the form of chorionic villus sampling or amniocentesis. Although precise, these tests are invasive and may result in intrauterine infection and miscarriage. Recently, fetal genetic material (found in maternal blood) has been used to screen for fetal aneuploidy in high-risk women. Now a simple blood draw can detect chromosomal abnormalities during pregnancies. However, the limitations of cell-free DNA screening…
Read MoreSynthetic Stem Cells Mend Damaged Heart Tissue
Adult stem cells have the ability of self-regeneration and differential plasticity, which allows them to play a key role in cell-mediated cardiovascular regenerative therapies. One such adult stem cell, mesenchymal stem cell (MSC), is widely used in preclinical and clinical studies on the regeneration of cardiac function and structure after acute myocardial infarction. A primary mechanism of MSCs therapeutic effects is the release of soluble factors that promote regeneration of the damaged tissue. The major challenge to overcome with MSCs as a…
Read MoreCGT Global Best Sellers on Biocompare
We want to hear from you! At StemExpress we are constantly striving to offer our customers the highest quality products. By receiving feedback from you, we can determine what’s working and what needs improving. Share your experience with our products on Biocompare and tell us what you think. Receive an Amazon gift card from Biocompare when you write a review about one of our products. Simply select “Assay Kits/Reagents” and begin the review process. Each review is checked for accuracy and completeness by Biocompare.…
Read MoreLaunch of CGT Global Products on Fisher Scientific
Ordering StemExpress products just got easier! Fisher Scientific, a one-stop online ordering catalog for your lab equipment and supplies, will now carry our best selling products to allow convenient shopping for your research needs. Check out our lineup of products to see what we currently offer at Fisher Scientific. For additional information, please contact one of our sales specialists at 530-303-3828.
Read MorePersonalized medicine has taken a leap forward with advances in chimeric antigen receptor (CAR)-T cell therapy
CAR-T Cell Therapy Treatments for cancers of the blood have been historically based on surgery, chemotherapy, and radiation therapy with more recent treatments focused on adoptive T cell therapy (ACT). ACT is most commonly applied by isolating tumor-infiltrating lymphocytes, which are naturally enriched from tumor-specific T cells, expanded in culture, and reintroduced back into the patient. Although this was a major breakthrough using ACT, the results had limited success on patients. Within the last few years, chimeric antigen receptor (CAR)-T cell therapy…
Read MoreNew CGT Global G-CSF Mobilized Leukopaks
G-CSF Mobilized Leukopaks StemExpress introduces G-CSF Mobilized Leukopaks to their extensive collection of blood-derived cell products. After two years of working with their clients to develop a protocol in which institute protocol standards were evaluated, a mobilized Leukopak procedure was developed to bring a high-quality product to clients demanding low granulocyte contamination, high cell viability, and an increase in CD34+ cell frequencies. According to Joe Anderson, Ph.D., Assistant Professor of Internal Medicine at UC Davis, “we worked closely with StemExpress to obtain a…
Read MoreCGT Global CEO Inspires Entrepreneurs at UCD Ignite Conference
StemExpress CEO, Cate Dyer, was a keynote speaker for the UCD Ignite Conference on March 3rd, 2017. Ignite is a four-day summit where innovative MBA and Ph.D. students from various top-level business programs learn from some of the most successful and up-and-coming entrepreneurs in Silicon Valley and other hubs of innovation and entrepreneurship. Check out the video below!
Read More